News
-
-
-
COMMUNIQUÉ DE PRESSE
BioNxt Advances Semaglutide Oral Dissolvable Film (ODF) Program with Successful Proof-of-Concept and Prototype Development
BioNxt achieves successful proof-of-concept trials for Semaglutide oral dissolvable film program, advancing to next development phase in GLP-1 market for diabetes and obesity therapies -
-
-
-
-
-
-